| Entry |
|
|---|
| Name |
Budipine (INN) |
|---|
| Formula |
C21H27N
|
|---|
| Exact mass |
293.2144
|
|---|
| Mol weight |
293.4458
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiparkinsonian |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04B DOPAMINERGIC AGENTS
N04BX Other dopaminergic agents
N04BX03 Budipine
D07306 Budipine (INN)
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D07306 Budipine (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 22
1 C8x C 15.4000 -18.4100
2 C8x C 15.4000 -19.8100
3 C8x C 16.6124 -20.5100
4 C8x C 17.8249 -19.8100
5 C8y C 17.8249 -18.4100
6 C8x C 16.6124 -17.7100
7 C1z C 19.0560 -17.6990
8 C8y C 20.2612 -18.3947
9 C8x C 20.2616 -19.8096
10 C8x C 21.4742 -20.5093
11 C8x C 22.6865 -19.8089
12 C8x C 22.6860 -18.3939
13 C8x C 21.4734 -17.6943
14 C1x C 20.2516 -17.0086
15 C1x C 20.2515 -15.6086
16 N1y N 19.0390 -14.9087
17 C1x C 17.8434 -15.5991
18 C1x C 17.8435 -16.9991
19 C1d C 19.0389 -13.5100
20 C1a C 19.0389 -12.1100
21 C1a C 17.6400 -13.5101
22 C1a C 20.4400 -13.5099
BOND 24
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 7 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 7 18 1
21 16 19 1
22 19 20 1
23 19 21 1
24 19 22 1
|
|---|
